未登录

I

Islam M. Ghazi

New York University Abu Dhabi

H指数:11

被引数:461

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pharmacokinetic Assessment of Ceftazidime/Avibactam in Patients Undergoing Renal Replacement Therapy

肾替代治疗患者中他唑巴坦/阿维巴坦的药代动力学评估

Journal of Pharmacology and Experimental Therapeutics

IF3.8

2026-05-010

PRE

Innate immune response to bacterial infections in hospitalized glucose-6-phosphate dehydrogenase-deficient patients; diagnostic value of white blood cell count

住院葡萄糖-6-磷酸脱氢酶缺乏症患者对细菌感染的先天免疫反应；白细胞计数的诊断价值

Clinical Immunology

IF5.7

2025-10-160

PRE

Clinical Outcomes of Ceftazidime-Avibactam versus Ceftolozane-Tazobactam in Managing Pseudomonal Infections in Patients Undergoing Renal Replacement Therapy

ANTIBIOTICS-BASEL

IF4.6

2024-07-260

OA

Clinical Outcomes of Trimethoprim/Sulfamethoxazole in Critically Ill Patients with Stenotrophomonas maltophilia Bacteremia and Pneumonia Utilizing Renal Replacement Therapies

JOURNAL OF CLINICAL MEDICINE

IF2.9

2024-04-140

OAAI

Infections in Glucose-6-Phosphate Dehydrogenase G6PD-Deficient Patients; Predictors for Infection-Related Mortalities and Treatment Outcomes

ANTIBIOTICS-BASEL

IF4.6

2023-03-013

OA

Acinetobacter baumannii Infection-Related Mortality in Hospitalized Patients: Risk Factors and Potential Targets for Clinical and Antimicrobial Stewardship Interventions

ANTIBIOTICS-BASEL

IF4.6

2022-08-1045

OA

Infections in G6PD-Deficient Hospitalized Patients-Prevalence, Risk Factors, and Related Mortality

ANTIBIOTICS-BASEL

IF4.6

2022-07-124

OAAI

Acinetobacter baumannii Infections in Hospitalized Patients, Treatment Outcomes

ANTIBIOTICS-BASEL

IF4.6

2021-05-2518

OAAI

Y-site Administration of Imipenem/Cilastatin/Relebactam With Common Intravenous Medications

CLINICAL THERAPEUTICS

IF3.6

2020-03-017

OAAI

Antibacterial activity of human simulated epithelial lining fluid concentrations of amikacin inhale alone and in combination with meropenem against Acinetobacter baumannii

INFECTIOUS DISEASES

IF2.3

2017-07-315

PREAI

Antibiotic Utilization and Opportunities for Stewardship Among Hospitalized Patients With Influenza Respiratory Tract Infection

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

IF3

2016-02-0123

OAAI

Efficacy of Humanized High-Dose Meropenem, Cefepime, and Levofloxacin against Enterobacteriaceae Isolates Producing Verona Integron-Encoded Metallo-β-Lactamase (VIM) in a Murine Thigh Infection Model

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2015-11-0115

OAAI